<DOC>
	<DOCNO>NCT02515708</DOCNO>
	<brief_summary>Normothermic machine perfusion ( NMP ) preservation promise method decrease complication marginal donor liver compare cold storage ( CS ) . The aim project ass safety feasibility NMP human liver transplantation . This single center prospective cohort pilot study . Thirty-two liver acceptable quality transplantation preserve NMP 4-18 hour transplant . The follow-up period 6 month post-transplantation . The outcome compare 128 historical patient transplant program past 5 year ( liver preserve use CS ) match characteristic age , Model End-Stage Liver Disease ( MELD ) score , preservation time , etc .</brief_summary>
	<brief_title>Pilot Study Assess Safety Feasibility Normothermic Machine Preservation In Human Liver Transplantation</brief_title>
	<detailed_description>The shortage donor organ lead use marginal donor include donor cardiac death . Normothermic machine perfusion ( NMP ) preservation promise method decrease high risk complication compare standard cold storage ( CS ) . The aim project ass safety feasibility NMP human liver transplantation . This single center prospective cohort pilot study . Thirty-two liver acceptable quality transplantation preserve NMP 4-18 hour cross clamp cold flush . The liver graft NMP physiological temperature oxygen nutrient supply continuous perfusion . The transplantation post-transplant care follow standard care . The follow-up period 6 month transplantation . The primary end point rate post-transplant Early Allograft Dysfunction ( EAD ) , secondary end point : primary non function ( PNF ) rate , 1 6 month patient graft survival , peak liver function test first 7 day transplantation , intraoperative hepatic arterial portal flow measurement , rate magnitude post-reperfusion syndrome , surgical outcome ( operative time , transfusion requirement etc . ) , rate post-transplant kidney failure , assessment histological ischemia reperfusion ( liver bile duct ) , rate vascular complication , rate biliary complication , hospital ICU length stay , rejection rate , infection rate , ability predict function base `` on-pump '' viability marker , incidence adverse effect ( AE ) . The outcome compare control group 128 historical patient ( match 1:4 ratio ) transplant program past 5 year ( liver preserve use CS ) . Control subject match use donor recipient age , Model End-Stage Liver Disease ( MELD ) score , cold ischemia time , donor risk index presence steatosis .</detailed_description>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Patients undergo primary liver transplantation Age 1875 year time transplantation Willingness ability comply study procedure Signed Informed Consent Form For patient hepatocellular carcinoma indication Orthoptic Liver Transplantation ( OLT ) , tumor must within Milan Criteria downstaged Milan Criteria . Recipient History prior solid organ transplantation Patient respiratory and/or cardiocirculatory support time transplant MELD score &gt; 35 HIV positive patient Patient current severe systemic infection Multiorgan transplant Donor Donor age &lt; 14 &gt; 70 year Liver steatosis ( visual estimate liver biopsy ) &gt; 30 % Donors Grade 23 traumatic liver laceration Partial graft ( live donor split liver donor ) Liver investigator unwilling unable ( logistical reason ) perform normothermic machine perfusion ( NMP ) preservation Inability NMP perfuse liver within 4 hour cross clamp</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>